---
title: "NP48925d Hereditary Angioedema Branded Medicines (Cinryze and Takhzyro)"
ocid: "ocds-r6ebe6-0000794852"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000794852"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000794852.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000794852.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-05-02"
---

# NP48925d Hereditary Angioedema Branded Medicines (Cinryze and Takhzyro)

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-r6ebe6-0000794852

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000794852)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000794852.json)

## Summary

The Common Services Agency, known as NHS National Services Scotland (NSS), has completed a procurement process for the supply of hereditary angioedema branded medicines, specifically Cinryze and Takhzyro, to NHS Scotland. Takeda UK Limited was awarded the contract through a limited procurement method, justified by the absence of competition due to exclusive rights. The procurement, which falls under the health industry category, has resulted in a framework agreement worth approximately £9.46 million. The contract was signed on 4th April 2025 and is active, covering the provision across NHS Scotland regions as per the National Health Service (Scotland) Act 1978 and related regulations.

This contract presents significant business growth opportunities, particularly for pharmaceutical companies specializing in rare disease treatments or those with existing intellectual property in the health sector. Companies with a strong portfolio in medicine manufacturing and those capable of securing exclusive rights are well-suited to compete in similar tenders. Such collaborations with NHS Scotland not only offer substantial financial benefits but also enhance a company’s reputation by association with prestigious public health service organisations.

## Notice

Supply of Hereditary Angioedema Branded Medicines (Cinryze(r) and Takhzyro(r)) to NHS Scotland.

### Lot Information

Lot 1

The Framework Agreement is for the supply of several hereditary angioedema (HAE) branded medicines to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

### Procurement Information

Competition for some of the medicines awarded to the Framework Agreement is absent for technical reasons, in accordance with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015. Some of the medicines awarded to the Framework Agreement are protected by exclusive rights, including intellectual property rights, in accordance with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY529529 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 2 May 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 4 Apr 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £9,461,556 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | TAKEDA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 2 May 2025 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY529529
- 4 Apr 2025 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR527622

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR527622
  NP48925d Hereditary Angioedema Branded Medicines (Cinryze and Takhzyro) - Supply of Hereditary Angioedema Branded Medicines (Cinryze(r) and Takhzyro(r)) to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY529529
  NP48925d Hereditary Angioedema Branded Medicines (Cinryze and Takhzyro) - Supply of Hereditary Angioedema Branded Medicines (Cinryze(r) and Takhzyro(r)) to NHS Scotland.

## Notice URLs

- http://
- http://www.hfs.scot.nhs.uk
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000794852

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000794852. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000794852.json.